Myomo Net Tangible Assets Over Time
| MYO Stock | USD 5.62 0.40 7.66% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Myomo Performance and Myomo Correlation. Myomo |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myomo. If investors know Myomo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myomo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.23) | Revenue Per Share 0.835 | Quarterly Revenue Growth 0.813 | Return On Assets (0.31) | Return On Equity (0.83) |
The market value of Myomo Inc is measured differently than its book value, which is the value of Myomo that is recorded on the company's balance sheet. Investors also form their own opinion of Myomo's value that differs from its market value or its book value, called intrinsic value, which is Myomo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myomo's market value can be influenced by many factors that don't directly affect Myomo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myomo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Myomo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myomo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Tangible Assets Analysis
Compare Myomo Inc and related stocks such as SINTX Technologies, ReShape Lifesciences, and Bone Biologics Corp Net Tangible Assets Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SINT | (3.4 M) | (3.4 M) | (3.4 M) | (3.4 M) | (3.4 M) | 5 M | 1.9 M | (3.4 M) | 8.4 M | 5.2 M | 25.8 M | 17.7 M | 5.7 M | 6.5 M | 7.7 M |
| RSLS | 20 M | 20 M | 11.9 M | 6.7 M | 6.7 M | 3.7 M | 2.9 M | 3 M | (5.3 M) | (4.6 M) | (12.5 M) | 25.2 M | 3.4 M | 3.1 M | 4 M |
| BBLG | (3.7 M) | (3.7 M) | (3.7 M) | (3.7 M) | (3.7 M) | (5.7 M) | (8.4 M) | (8.4 M) | (8.6 M) | (11.9 M) | (13.7 M) | 6.6 M | 6.6 M | 7.6 M | 7.9 M |
| TIVC | 2.4 M | 2.4 M | 2.4 M | 2.4 M | 2.4 M | 2.4 M | 2.4 M | 2.4 M | 2.4 M | 2.4 M | (1.2 M) | 13.3 M | 13.3 M | 15.3 M | 16 M |
| BJDX | (2.9 M) | (2.9 M) | (2.9 M) | (2.9 M) | (2.9 M) | (2.9 M) | (2.9 M) | (2.9 M) | (2.9 M) | (2.9 M) | (4.2 M) | 20.4 M | 11.5 M | 13.3 M | 6.8 M |
| VVOS | (57 K) | (57 K) | (57 K) | (57 K) | (57 K) | (57 K) | (57 K) | (57 K) | (57 K) | (6.3 M) | 14 M | 22.4 M | 22.4 M | 25.7 M | 27 M |
| RPID | (79.6 M) | (79.6 M) | (79.6 M) | (79.6 M) | (79.6 M) | (79.6 M) | (79.6 M) | (79.6 M) | (79.6 M) | (79.6 M) | (121.3 M) | 221 M | 162.8 M | 187.2 M | 196.5 M |
| NUWE | 16.2 M | 16.2 M | 16.2 M | 16.2 M | 16.2 M | 16.2 M | 16.2 M | 16.2 M | 5.9 M | 2 M | 16.3 M | 25.9 M | 12.4 M | 14.2 M | 14.4 M |
| HSCS | 315.1 K | 315.1 K | 315.1 K | 315.1 K | 315.1 K | 315.1 K | 315.1 K | 315.1 K | 315.1 K | 315.1 K | (1.9 M) | (6.1 M) | 230.2 K | 207.2 K | 217.5 K |
| NXL | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.6 M) | (1.7 M) | 5.5 M | 6.3 M | 6.6 M |
| IRIX | 21.1 M | 21.1 M | 20.8 M | 25 M | 32.9 M | 32.9 M | 38.5 M | 29.9 M | 29.3 M | 22.1 M | 16.8 M | 20.1 M | 14.3 M | 12.9 M | 20.2 M |
| SGHT | (29 M) | (29 M) | (29 M) | (29 M) | (29 M) | (29 M) | (29 M) | (29 M) | (29 M) | (54.7 M) | (88.8 M) | 232.1 M | 160.1 M | 184.1 M | 193.3 M |
| SSKN | 29.7 M | 29.7 M | 13.9 M | 12.2 M | 12.2 M | (8.1 M) | (7.5 M) | 2.1 M | 12.7 M | 11.9 M | 10.7 M | 6.5 M | 6.5 M | 5.9 M | 6.7 M |
| NVNO | (12.2 M) | (12.2 M) | (12.2 M) | (12.2 M) | (12.2 M) | (12.2 M) | (12.2 M) | (12.2 M) | 1.4 M | 989.9 K | 7.1 M | 54.4 M | 38.7 M | 44.5 M | 46.8 M |
Myomo Inc and related stocks such as SINTX Technologies, ReShape Lifesciences, and Bone Biologics Corp Net Tangible Assets description
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.My Equities
My Current Equities and Potential Positions
| Myomo Inc | MYO |
| Classification | Medical Equipment |
| Location | Massachusetts; U.S.A |
| Exchange | NYSE MKT Exchange |
USD 5.62
Check out Myomo Performance and Myomo Correlation. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Myomo technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.